NasdaqGS - Delayed Quote USD
Regeneron Pharmaceuticals, Inc. (REGN)
At close: October 17 at 4:00 PM EDT
After hours: October 17 at 7:21 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 403,134 | 25 |
| Sales | 229,131 | 32 |
| Net Shares Purchased (Sold) | 174,003 | 57 |
| Total Insider Shares Held | 1.65M | -- |
| % Net Shares Purchased (Sold) | 11.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MCCOURT MARION E Officer | Sale at price 1054.06 per share. | Direct | 1,054,060 | Oct 1, 2024 |
| RYAN ARTHUR F Director | Sale at price 1041.35 - 1059.28 per share. | Direct | 104,878 | Oct 1, 2024 |
| MCCOURT MARION E Officer | Conversion of Exercise of derivative security at price 381.40 per share. | Direct | 381,400 | Oct 1, 2024 |
| SING GEORGE LOUIS Director | Stock Gift at price 0.00 per share. | Direct | 0 | Sep 4, 2024 |
| MCCOURT MARION E Officer | Sale at price 1178.73 per share. | Direct | 1,178,730 | Sep 3, 2024 |
| RYAN ARTHUR F Director | Sale at price 1166.52 - 1191.02 per share. | Direct | 117,868 | Sep 3, 2024 |
| MCCOURT MARION E Officer | Conversion of Exercise of derivative security at price 381.40 per share. | Direct | 381,400 | Sep 3, 2024 |
| FENIMORE CHRISTOPHER R Chief Financial Officer | Sale at price 1204.71 - 1206.70 per share. | Indirect | 6,846,262 | Aug 28, 2024 |
| BASSLER BONNIE L Director | Sale at price 1170.00 per share. | Direct | 884,520 | Aug 15, 2024 |
| POON CHRISTINE A Director | Sale at price 1155.72 - 1161.32 per share. | Direct | 12,552,284 | Aug 15, 2024 |
| BASSLER BONNIE L Director | Conversion of Exercise of derivative security at price 371.40 per share. | Direct | 280,778 | Aug 15, 2024 |
| POON CHRISTINE A Director | Conversion of Exercise of derivative security at price 413.33 per share. | Direct | 4,479,671 | Aug 15, 2024 |
| MURPHY ANDREW J Officer | Sale at price 1140.31 - 1159.69 per share. | Direct | 7,337,505 | Aug 14, 2024 |
| MURPHY ANDREW J Officer | Conversion of Exercise of derivative security at price 399.66 per share. | Direct | 7,993,200 | Aug 13, 2024 |
| STAHL NEIL E Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 13, 2024 |
| STAHL NEIL E Officer | Stock Gift at price 0.00 per share. | Direct | 0 | Aug 12, 2024 |
| STAHL NEIL E Officer | Sale at price 1081.83 - 1086.15 per share. | Direct | 5,636,346 | Aug 8, 2024 |
| PITOFSKY JASON Officer | Sale at price 1070.00 per share. | Direct | 521,090 | Aug 7, 2024 |
| PITOFSKY JASON Officer | Conversion of Exercise of derivative security at price 372.46 per share. | Direct | 181,388 | Aug 7, 2024 |
| BASSLER BONNIE L Director | Sale at price 1115.00 per share. | Direct | 842,940 | Aug 2, 2024 |
| BASSLER BONNIE L Director | Conversion of Exercise of derivative security at price 371.40 per share. | Direct | 280,778 | Aug 2, 2024 |
| STAHL NEIL E Officer | Conversion of Exercise of derivative security at price 555.67 per share. | Direct | 13,134,927 | Aug 2, 2024 |
| MCCOURT MARION E Officer | Sale at price 1060.86 per share. | Direct | 1,206,198 | Aug 1, 2024 |
| RYAN ARTHUR F Director | Sale at price 1053.22 - 1099.65 per share. | Direct | 107,467 | Aug 1, 2024 |
| RYAN ARTHUR F Director | Sale at price 1100.03 per share. | Direct | 1,100 | Aug 1, 2024 |
| MCCOURT MARION E Officer | Conversion of Exercise of derivative security at price 372.46 per share. | Direct | 423,487 | Aug 1, 2024 |
| LAROSA JOSEPH J General Counsel | Sale at price 1088.95 per share. | Direct | 2,031,981 | Jul 11, 2024 |
| MCCOURT MARION E Officer | Sale at price 1047.11 per share. | Direct | 1,190,564 | Jul 1, 2024 |
| RYAN ARTHUR F Director | Sale at price 1047.11 - 1068.09 per share. | Direct | 105,924 | Jul 1, 2024 |
| MCCOURT MARION E Officer | Conversion of Exercise of derivative security at price 372.46 per share. | Direct | 423,487 | Jul 1, 2024 |
| BASSLER BONNIE L Director | Sale at price 1062.00 per share. | Direct | 802,872 | Jun 24, 2024 |
| BASSLER BONNIE L Director | Conversion of Exercise of derivative security at price 371.40 per share. | Direct | 280,778 | Jun 24, 2024 |
| LAROSA JOSEPH J General Counsel | Conversion of Exercise of derivative security at price 555.67 per share. | Direct | 8,029,432 | Jun 24, 2024 |
| BROWN MICHAEL S Director | Sale at price 1040.00 per share. | Direct | 1,596,400 | Jun 14, 2024 |
| BROWN MICHAEL S Director | Conversion of Exercise of derivative security at price 625.60 per share. | Direct | 960,296 | Jun 14, 2024 |
| SCHLEIFER LEONARD S Chief Executive Officer | Sale at price 1015.28 - 1025.27 per share. | Indirect | 25,610,229 | Jun 12, 2024 |
| SCHLEIFER LEONARD S Chief Executive Officer | -- | Indirect | -- | Jun 12, 2024 |
| YANCOPOULOS GEORGE D President | Stock Gift at price 0.00 per share. | Indirect | 0 | Jun 10, 2024 |
| LAROSA JOSEPH J General Counsel | Stock Gift at price 0.00 per share. | Indirect | 0 | Jun 10, 2024 |
| SCHLEIFER LEONARD S Chief Executive Officer | Sale at price 1015.02 per share. | Indirect | 798,821 | Jun 6, 2024 |
| BASSLER BONNIE L Director | Sale at price 1011.00 per share. | Direct | 836,097 | Jun 5, 2024 |
| BASSLER BONNIE L Director | Conversion of Exercise of derivative security at price 380.95 per share. | Direct | 315,046 | Jun 5, 2024 |
| MCCOURT MARION E Officer | Sale at price 980.16 per share. | Direct | 1,115,422 | Jun 3, 2024 |
| RYAN ARTHUR F Director | Sale at price 979.40 - 1000.04 per share. | Direct | 99,450 | Jun 3, 2024 |
| MCCOURT MARION E Officer | Conversion of Exercise of derivative security at price 372.46 per share. | Direct | 423,859 | Jun 3, 2024 |
| BROWN MICHAEL S Director | Sale at price 974.86 per share. | Direct | 1,142,536 | May 28, 2024 |
| BROWN MICHAEL S Director | Conversion of Exercise of derivative security at price 625.60 per share. | Direct | 733,203 | May 28, 2024 |
| LAROSA JOSEPH J General Counsel | Sale at price 994.90 per share. | Direct | 1,855,488 | May 21, 2024 |
| SCHLEIFER LEONARD S Chief Executive Officer | Sale at price 979.22 - 980.07 per share. | Direct | 22,355,714 | May 17, 2024 |
| YANCOPOULOS GEORGE D President | Sale at price 967.40 - 978.18 per share. | Direct | 48,636,545 | May 16, 2024 |
Related Tickers
VRTX Vertex Pharmaceuticals Incorporated
498.73
+2.36%
ALNY Alnylam Pharmaceuticals, Inc.
296.75
-1.26%
BMRN BioMarin Pharmaceutical Inc.
69.47
-0.98%
NVO Novo Nordisk A/S
118.22
+0.16%
VKTX Viking Therapeutics, Inc.
64.62
-1.88%
ARGX argenx SE
543.84
+0.60%
EXEL Exelixis, Inc.
29.06
-0.99%
UTHR United Therapeutics Corporation
372.81
+0.77%
BNTX BioNTech SE
114.47
-2.78%
SRPT Sarepta Therapeutics, Inc.
124.25
-1.33%